Capstone Investment Advisors, LLC Sarepta Therapeutics, Inc. Transaction History
Capstone Investment Advisors, LLC
- $30.4 Billion
- Q3 2024
A detailed history of Capstone Investment Advisors, LLC transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Capstone Investment Advisors, LLC holds 6,000 shares of SRPT stock, worth $670,920. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,000Holding current value
$670,920% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding SRPT
# of Institutions
528Shares Held
85MCall Options Held
2.06MPut Options Held
1.52M-
Black Rock Inc. New York, NY10.3MShares$1.15 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.97MShares$1 Billion0.02% of portfolio
-
Capital International Investors Los Angeles, CA6.26MShares$700 Million0.16% of portfolio
-
Janus Henderson Group PLC London, X04.36MShares$487 Million0.29% of portfolio
-
State Street Corp Boston, MA4.27MShares$478 Million0.02% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $9.79B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...